Business
Bausch Health Announces Second Quarter 2024 Results
Second quarter consolidated revenues of $2.40 billion, up 11% on a Reported and 8% on an Organic ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health Announces Second Quarter 2024 ResultsSecond quarter consolidated revenues of $2.40 billion, up 11% on a Reported and 8% on an Organic (non-GAAP)1 basisConsolidated GAAP Net Income Attributable to Bausch Health Companies Inc. of $10 millionConsolidated Adjusted EBITDA Attributable to Bausch Health Companies Inc. (non-GAAP)1 of $798 million, up 10%Raising consolidated full-year Revenue and Adjusted EBITDA (non-GAAP)1 guidanceLAVAL, QC / ACCESSWIRE / August 1, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (\"Bausch Health\" or the \"Company\" or \"we\" or \"our\") today announced its second quarter 2024 financial results and other key updates from the quarter.\"We continued our momentum in the second quarter, delivering our fifth consecutive quarter of year-over-year growth in revenues and adjusted EBITDA, underscoring the strength of our product and geographic footprint and reinforcing our strategy. We remain focused on advancing our R&D pipeline, strengthening our balance sheet and executing on our commercial strategies to drive growth globally. I'm proud of the hard work and accomplishments of our team, who work tirelessly to improve the health of patients worldwide,\" said Thomas J. Appio, Chief Executive Officer, Bausch Health.Second Quarter 2024 Revenue PerformanceTotal consolidated reported revenues were $2.40 billion for the second quarter of 2024, compared with $2.17 billion in the second quarter of 2023, an increase of $236 million, or 11%. Excluding the impact of foreign exchange of $25 million, acquisitions of $104 million, and divestitures and discontinuations of $14 million, revenue increased by 8% organically1 compared with the second quarter of 2023.Reported revenues by segment were as follows: Three Months EndedJune 30, Reported Change Change atConstantCurrency1 Change in OrganicRevenue1 (in millions) 2024 2023 Amount Pct. (Non-GAAP) (Non-GAAP) Total Bausch Health Revenues $2,403 $2,167 $236 11% 12% 8% Bausch Health (excl. B+L) $1,187 $1,132 $55 5% 5% 6%Salix segment $558 $557 $1 -% -% 1%International segment $276 $259 $17 7% 5% 6%Solta Medical segment $102 $88 $14 16% 19% 19%Diversified segment $251 $228 $23 10% 10% 12%Bausch + Lomb segment $1,216 $1,035 $181 17% 20% 10%1 This is a non-GAAP measure or a non-GAAP ratio. For further information on non-GAAP measures and non-GAAP ratios, pl...